Compare

MOTS-c vs SS-31

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.
XRedditFacebook

MOTS-c

111 community reports

Positive 17% · Neutral 2% · Negative 81%

Most reported benefits

Appetite
230
Energy
45
Mood
1
Recovery
1

Most reported side effects

Injection site irritation
191

Dose distribution

Median: 2000+ mcg · Most common: 2000+ mcg

0–25
4
25–50
0
50–100
0
100–200
1
200–400
8
400–600
11
600–1000
8
1000–2000
42
2000+
157

How repeat users are trending

Among repeat reporters, 56% said they felt similar to their last entry, 31% more positive, and 13% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 44 days · Based on 45 repeat reporters

SS-31

58 community reports

Positive 2% · Neutral 2% · Negative 96%

Most reported benefits

Energy
187

Most reported side effects

Injection site irritation
183

Dose distribution

Median: 2000+ mcg · Most common: 2000+ mcg

0–25
0
25–50
10
50–100
0
100–200
0
200–400
2
400–600
1
600–1000
4
1000–2000
18
2000+
151

How repeat users are trending

Among repeat reporters, 92% said they felt similar to their last entry, 8% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 73 days · Based on 37 repeat reporters